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To assess the electrophysiologic effects of acute hemody- 
namic improvement in patients with left ventricular systolic 
dysfunction, 12 patients with a left ventricular ejection 
fraction CO.40 and a history of sustained monomorphic 
ventricular tachycardia were studied. All patients had 
underlying coronary artery disease. Patients underwent 
programmed cardiac stimulation in random order during a 
baseline period and with nitroprusside infusion. Mean 
pulmonary capillary wedge pressure decreased from 20 + 8 
mm Hg at baseline study to 8 f 3 mm Hg during nitro- 
prusside infusion (p < 0.0001). Pulmonary artery, right 
atrial and systemic arterial pressures also decreased with 
nitroprusside (p < 0.01). Cardiac output did not change. 
Left ventricular dimensions, determined by two-dimen- 
sional echocardiography, decreased significantly during 
nitroprusside infusion. 
The right ventricular effective refractory period, mea- 
sured during ventricular drive trains at cycle lengths of 400 
and 600 ms, were similar during baseline and nitroprus- 
side periods (271 f 30 versus 274 + 31 ms at 600 ms, and 
249 f 25 versus 246 f 18 ms at 400 ms). In 2 patients no 
ventricular arrhythmias were induced during either study 
period; in the other 10, ventricular tachyarrhythmias were 
induced during both periods. The mean number of extra- 
stimuli required to induce a ventricular tachyarrhythmia 
was similar during the baseline period (1.8 + 0.6) and 
during nitroprusside infusion (1.9 f 0.7). As well, the mean 
cycle length of ventricular tachycardia induced was similar 
during the baseline period (347 2 61 ms) and during 
nitroprusside infusion (342 + 70 ms). 
Thus, in patients with left ventricular systolic dysfunc- 
tion and ventricular tachycardia due to coronary artery 
disease, acute hemodynamic improvement with a reduction 
in left ventricular size does not affect characteristics of 
ventricular tachycardia induction. Determination of 
whether long-term vasodilator treatment affects these char- 
acteristics requires further study. 
(J Am Co11 Cardiol1989;14:1744-52) 
Clinical studies have demonstrated an association between 
heart failure and the occurrence of ventricular tachyarrhyth- 
mias. Up to 87% of patients with heart failure have complex 
ventricular ectopic activity (1). The frequency and complex- 
ity of ventricular arrhythmias are related to mortality and the 
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severity of congestive heart failure (2-7). Furthermore, 
approximately 50% of deaths in patients with congestive 
heart failure occur suddenly, suggesting an arrhythmic origin 
(8). Proarrhythmic factors associated with rhythm distur- 
bances in congestive heart failure include left ventricular 
dysfunction and segmental wall motion abnormalities (3-9). 
Changes in ventricular muscle length and tension associated 
with these factors may induce electrophysiologic abnormal- 
ities that predispose to arrhythmias (10-16). Two studies 
(17,18) demonstrated that vasodilators increased survival 
rates in patients with heart failure. Two other studies (19,20) 
showed that patients with heart failure have less ventricular 
ectopic activity while taking an angiotensin-converting en- 
zyme inhibitor. 
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Table 1. Characteristics of the 15 Study Patients 
Patient Age (yr)l 
No.* Gender Diseased Vesselt LVEF RWMA Antiarrhythmic Drug 
Order of 
Study 
Periods 
48/M 
41/M 
LAD. RCA 
LAD, LCx, RCA 
0.09 
0.3 I 
.4pical akinesia 
Septal dyskinesia. anterior 
akinesia 
Anteroapical akinesia 
Apical dyskinesia 
Apical akinesia 
Apical dyskinesia. anterior 
akineGa 
Anteroapical and inferior 
akineria 
Anteroapical dyskinesia 
lnferoapical akinesia 
Septal dyskinesia. apical 
akine\ia 
Posterior akmesia 
lnferoposterior akinesia 
Anteroapical dyskinesia 
Apical dyskinesia. anterior 
and inferior akinesia 
Inferoapical akinesia 
Amiodarone 
Procainamide 
B, N 
N. B 
48/F 
63/M 
62/M 
68/F 
LAD 
LAD 
LAD, LCx, RCA 
LAD 
0.25 
0.31 
0.31 
0.25 
Quinidine N. B 
Quinidine B, N 
Sotalol B, N 
Sotalol N. B 
65/M LAD, LCx, RCA 0.10 Procainamide 8, N 
8 49/M 
9 SO/M 
IO 66/M 
LAD, RCA 0.29 
LCx, RCA 0.35 
LAD, LCx. RCA 0.33 
Amiodarone B. N 
Sotalol B, N 
Sotalol B. N 
11 
12 
I3 
I4 
66/M LCX 0.24 
63/M RCA 0.27 
53/M LAD 0.23 
60/M LAD, LCx. RCA 0.12 
Quinidine, mexiletine N. B 
Sotalol B. N 
None B 
Procainamide. tocainide N 
I5 52/M LCx, RCA 0.24 Sotalol B 
*Patients are listed in chronological order, except for Patients 13, 14 and 15. who were excluded from analysis after induction of ventricular fibrillation in the 
initial study period. Patients 1 through I2 in subsequent tables correspond to Patients I through 12 in this table. tA vessel was judged to be diseased if ~70% 
diameter stenosis was present on coronary angiography. B = baseline; F = female; LAD = left anterior descending coronary artery: LCx = left circumflex 
nitroprusside: RCA = right coronary artery: RWMA = regional wall motion coronary artery: LVEF = left ventricular ejection fraction; M = male; N 
abnormalities (akinesia or dyskinesia). 
Although the association between heart failure and ven- 
tricular arrhythmias is evident, no study has assessed 
whether an acute improvement in the hemodynamic state 
decreases the susceptibility to these arrhythmias. The pur- 
pose of this study was to determine whether acute hemody- 
namic improvement with reduction in ventricular size affects 
the induction of ventricular tachycardia in patients with 
sustained monomorphic ventricular tachycardia and left 
ventricular dysfunction. 
To bring about such acute changes in pressures and 
volumes, we administered nitroprusside, a rapid-acting 
“pure” vasodilator without known direct myocardial ef- 
fects. We specifically sought to determine whether the 
efficacy (or lack of efficacy) of antiarrhythmic drugs is 
influenced by such acute hemodynamic changes. 
left ventricular segmental wall motion abnormalities. Three 
patients (Patients 2, 3 and 6) had undergone left ventricular 
aneurysmectomy. The mean left ventricular ejection fraction 
was 0.25 F 0.08. No patient had clinically decompensated 
heart failure at the time of study. Until 24 hours before 
study, two patients were taking nitrates, 3 were taking 
nitrates and captopril, 1 was taking nifedipine, 1 was taking 
nitrates and diltiazem, and eight were taking no vasodilators. 
The six patients who had been taking vasodilators did not 
respond differently to programmed stimulation from the 
eight patients who had not been taking vasodilators. 
All 15 patients were in sinus rhythm and had had sus- 
tained monomorphic ventricular tachycardia induced during 
a previous electrophysiologic study while taking no antiar- 
rhythmic drugs. At the time of entry into the protocol. all but 
one patient were being treated with antiarrhythmic drugs. 
The protocol was approved by the Subcommittee for Human 
Studies, Committee on Research, Massachusetts General 
Hospital on August 26, 1985, and all subjects gave written 
informed consent. 
Study protocol. Digoxin, diuretic drugs and vasodilator 
drugs were discontinued 24 h before the study, but antiar- 
rhythmic drugs were administered as scheduled. Studies 
were performed with the patient under mild sedation (diaz- 
epam, 5 to 10 mg orally) and local anesthesia with 1% 
lidocaine. A 5F introducer was placed in the femoral artery 
Methods 
Study patients (Table 1). Criteria for entry into the study 
were a history of spontaneous sustained monomorphic ven- 
tricular tachycardia, a history of heart failure and a left 
ventricular ejection fraction (as determined by cineventric- 
ulography or gated blood pool scanning) ~0.40. Fifteen 
patients (13 men and 2 women, age 57 f 9 years) were 
enrolled. All had coronary artery disease, had experienced 
at least one prior myocardial infarction and had associated 
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to measure systemic arterial pressure. Under fluoroscopic 
guidance, a 7F balloon-tipped thermodilution Swan-Ganz 
catheter was introduced percutaneously through the right 
femoral vein and advanced to the pulmonary artery. A 6F 
quadripolar electrode catheter was introduced percutane- 
ously through the right femoral vein and advanced to the 
right ventricular apex, and ventricular capture was con- 
firmed. When ventricular tachycardia could not be induced 
from the right ventricular apex, the catheter was advanced to 
the outflow tract and stimulation was performed from that 
site. 
Patients were randomly assigned to undergo the initial 
electrophysiologic study during either the baseline period or 
nitroprusside infusion (Table 1). Intravenous sodium nitro- 
prusside was begun at 25 pg/min, and the dosage increased 
at 5 min intervals until the pulmonary capillary wedge 
pressure had decreased to approximately 50% of its baseline 
value. In patients randomized to undergo the first pro- 
grammed stimulation study during nitroprusside infusion, 
pressures were measured before nitroprusside was infused. 
After discontinuation of the nitroprusside infusion, systemic 
arterial and pulmonary capillary wedge pressures were al- 
lowed to return to baseline values for at least 10 min before 
the electrophysiologic study was repeated. 
Mean and phasic systemic arterial, pulmonary capillary 
wedge, pulmonary artery and right atria1 pressures were 
measured just before electrophysiologic studies in the base- 
line and nitroprusside periods. Cardiac output was deter- 
mined by the thermodilution method. Systemic arterial 
blood was sampled for oxygen saturation and central venous 
blood for fractionated plasma catecholamine concentration 
immediately before each electrophysiologic study. Two- 
dimensional echocardiography, including parasternal long- 
and short-axis and apical two and four chamber views, was 
performed before each of the two electrophysiologic studies 
in eight patients. Surface electrocardiographic (ECG) leads I 
and aVF, the right ventricular local electrogram, systemic 
arterial pressure and pulmonary artery pressure were con- 
tinuously monitored and recorded on a multichannel oscil- 
loscopic recorder (VR-16, Electronics for Medicine). Band- 
pass filters were set at 30 and 500 Hz, and recordings were 
made at 100 mm/s. Systemic arterial oxygen saturation was 
measured with an oximeter (Radiometer, Copenhagen 
OSM2). Plasma epinephrine and norepinephrine concentra- 
tions were determined by radioimmunoassay (Smith Kline 
Bio-Science Laboratories) (21). 
Programmed stimulation protocol. Diastolic threshold 
was determined at each ventricular stimulation site immedi- 
ately before programmed cardiac stimulation during both the 
baseline and the nitroprusside infusion study. Programmed 
stimulation was performed at the right ventricular apex with 
use of a programmable stimulator (model DTU 210, Bloom 
Associates Ltd.) that introduced 2 ms rectangular pulses at 
twice diastolic threshold. The stimulation protocol included 
single, double and triple extrastimuli, as previously de- 
scribed (22). Baseline and nitroprusside stimulation studies 
were performed without a change of electrode catheter 
position between the two trials. Programmed single and 
double extrastimuli were introduced during ventricular pac- 
ing after eight beat drive trains at cycle lengths of 400 and 
600 ms. Triple extrastimuli were introduced after an eight 
beat drive train at a cycle length of 400 ms. The coupling 
intervals were decreased by 10 ms decrements until refrac- 
toriness was encountered. The right ventricular effective 
refractory period was also measured using a single extra- 
stimulus after an eight beat drive train. The reproducibility 
of the measurement was confirmed in each case by repeating 
the programmed stimulation at coupling intervals immedi- 
ately before and when the ventricle was refractory to stim- 
ulation. 
The programmed stimulation protocol had three possible 
end points: 1) induction of sustained ventricular tachyar- 
rhythmia, defined as lasting >lOO beats or requiring inter- 
vention before that time because of hemodynamic deterio- 
ration; 2) reproducible induction of nonsustained ventricular 
tachycardia, defined as a run of 2 10 consecutive ventricular 
complexes lasting <30 s and terminating spontaneously; or 
3) completion of the protocol without induction of ventricu- 
lar tachyarrhythmia. 
A 12 lead surface ECG was obtained during each induced 
sustained ventricular arrhythmia. Induced ventricular tachy- 
cardia was terminated, when possible, by rapid ventricular 
pacing. When syncope occurred before ventricular pacing 
terminated the arrhythmia, direct current cardioversion 
using 200 J from an external defibrillator was performed. 
If a ventricular arrhythmia required direct current cardio- 
version during the initial electrophysiologic study, the pro- 
tocol was discontinued and the second induction was not 
performed. 
Data analysis. After each study, 12 lead ECGs of the 
ventricular tachycardias induced during the baseline period 
and during nitroprusside infusion were examined in blinded 
fashion. Ventricular tachycardias were considered morpho- 
logically identical when their mean QRS axes in both the 
frontal and the horizontal plane did not differ by >45”. Right 
and left bundle branch block mimicry was not used for 
morphologic classification because of the subjective nature 
of this criterion. 
Echocardiographic images were recorded on videotape 
and analyzed on a Sony SMC-7OG microcomputer by an 
investigator who was unaware of other data. End-diastolic 
and end-systolic images were subjected to planimetry with a 
lightpen, and measurements of ventricular dimensions were 
made. 
Statistical analysis. Data are presented as mean values t- 
SD. Comparisons between data from the baseline and nitro- 
prusside infusion periods were made by Student’s t test for 
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Tahle 2. Hemodvnamic and Neuroendocrine Measurements in 12 Patients 
Plasma Plasma 
Study PCW PA RA MAP CO NE Epi 
Patient No. Period (mm Hg) (mm Hg) (mm Hg) (mm Hg) (literslmin) (pdml) @g/ml) 
- 
1 
1 
3 
4 
5 
6 
7 
8 
9 
10 
II 
I2 
Mean t SD 
P< 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
B 
N 
17 29 I 100 3.9 304 I12 
8 18 I 82 4.4 240 II? 
I9 30 3 8 5.8 288 10 
5 8 2 70 7.0 492 92 
24 33 4 64 5.5 364 52 
8 17 0 SO 5.5 372 80 
24 29 8 II0 5.6 - - 
15 17 I 93 5.1 - - 
32 39 I3 IO? 4.2 316 420 
9 25 6 90 4.8 248 IO 
25 38 16 95 4.0 224 64 
4 14 0 70 3.5 648 IO 
32 32 15 103 3.6 144 IO 
12 12 0 77 3.5 150 IO 
11 16 4 92 5.7 244 IO 
4 IO 0 75 5.3 634 96 
I4 20 16 90 4.9 262 IO 
8 I3 I? 75 5.0 406 IO 
24 
9 
43 
26 
10 
12 
8 
2 
4 
2 
9is 
3t4 
0.01 
120 4.9 260 100 
85 5.0 524 296 
9 
5 
17 
12 
84 4.6 248 I16 
65 4.9 808 316 
12 
5 
17 
IO 
4.0 240 IO 
3.0 228 IO 
20 2 8 29 + 9 
823 I5 k 6 
0.0001 0.0001 
88 
54 
94 5 I4 
74 2 13 
0.0001 
4.7 r 0.8 263 5 57 83 + 120 
4.7 + 1.1 132 2 209 95 + 112 
NS 0.05 NS 
CO = cardiac output; Epi = epinephrine concentration; MAP = mean systemic arterial pressure: NE = 
norepinephrine concentration; PA = pulmonary artery pressure: PCW = pulmonary capillary wedge pressure: RA 
= right atrial pressure; other abbreviations as in Table 1. 
paired observations; statistical significance was set at p < 
0.05. 
Results 
Of the 15 patients enrolled in the study, 3 required direct 
current cardioversion during the first trial of programmed 
cardiac stimulation (Patients 13 to 15, Table 1). The protocol 
was terminated in these patients, and they were excluded 
from further analysis. Thus, the study group consisted of 12 
patients, all of whom were taking antiarrhythmic drugs. 
Hemodynamic and neuroendocrine measurements (Table 
2). The nitroprusside infusion rate was 68 t 42 pg/min. 
Mean pulmonary capillary wedge pressure decreased from 
20 ? 8 mm Hg during the baseline period to 8 2 3 mm Hg 
(p < 0.0001) during nitroprusside infusion. Mean pulmonary 
artery pressure decreased from 29 t 9 to 15 * 6 mm Hg 
(p < O.OOOl), right atria1 pressure from 9 + 5 to 3 ? 4 mm Hg 
(p < 0.01) and mean systemic arterial pressure from 94 5 14 
to 74 + 13 mm Hg (p < 0.0001) during nitroprusside infusion. 
Cardiac output did not change. 
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Table 3. Echocardiographic Measurements in 12 Patients 
Measurement Baseline Nitroprusside p Value 
Parasternal long-axis diameter 
(cm) 
Systole 
Diastole 
Short-axis area (cm’) 
Systole 
Diastole 
Apical four chamber area (cm2) 
Systole 
Diastole 
Apical four chamber length (cm) 
Systole 
Diastole 
Apical two chamber area (cm’) 
Systole 
Diastole 
Apical two chamber length (cm) 
Systole 
Diastole 
5.16 + 0.90 
5.99 k 0.98 
21.9 k 4.7 
28.3 L 6.2 
39.4 _t 12.4 
45.4 ” 13.4 
8.70 t 1.05 
9.44 t 1.30 
39.6 c 13.5 
45.2 ? 15.3 
8.74 + 1.17 
9.40 k 1.30 
4.80 + 0.87 
5.61 f 0.86 
17.7 ‘- 4.1 
24.0 ” 4.4 
36.7 k 13.3 
42.3 ? 13.8 
8.40 + 1.18 
8.99 c 1.31 
36.2 + 12.3 
41.8 + 15.6 
8.46 k 1.25 
9.07 k I.25 
<O.OQOl 
CO.01 
<0.005 
<O.Ol 
NS 
<0.05 
NS 
NS 
-Co.02 
<O.Ol 
NS 
NS 
A small but statistically significant decrease in systemic 
arterial oxygen saturation occurred during nitroprusside 
infusion (0.96 ? 0.02 to 0.94 ? 0.02, p < 0.003). Plasma 
norepinephrine and epinephrine concentrations varied over 
a wide range during the baseline and nitroprusside periods. 
Mean plasma norepinephrine concentration was higher dur- 
ing nitroprusside infusion, whereas epinephrine concentra- 
tion did not change significantly. 
Echocardiographic measurements (Table 3). Left ventric- 
ular diameter measured in the parasternal long-axis view and 
cross-sectional area measured in the parasternal short-axis 
and apical two chamber views decreased during nitroprus- 
side infusion. Left ventricular length measured in the apical 
two and four chamber views during diastole and systole was 
smaller during nitroprusside infusion, but the differences did 
not reach statistical significance. 
Electrophysiologic measurements (Table 4). Sinus cycle 
length was longer during the baseline period (937 5 242 ms) 
than during nitroprusside infusion (812 2 213 ms, p < 
0.0002). The right ventricular effective refractory period 
measured at the apex was encountered before induction of 
an arrhythmia during both trials of programmed stimulation 
in 10 patients at a ventricular drive train cycle length 600 ms 
and in 7 patients at a drive train cycle length 400 ms. At a 
ventricular drive train cycle length of 600 ms, the mean 
effective refractory period during the baseline (271 * 30 ms) 
and nitroprusside infusion (274 t 3 1 ms) periods was similar. 
Baseline mean effective refractory period at a drive train 
cycle length of 400 ms (249 5 25 ms) also did not significantly 
change during nitroprusside infusion (246 2 18 ms). 
Response to programmed cardiac stimulation (Table 4). 
Two patients (Patients 4 and 8) had no ventricular tachycar- 
dia induced during either the baseline period or during 
nitroprusside infusion (Fig. 1). In the remaining 10 patients, 
ventricular tachyarrhythmias were induced from the right 
ventricular apex during both periods. Sustained ventricular 
tachycardia was induced in eight patients, and nonsustained 
ventricular tachycardia was reproducibly induced in one 
patient during both study periods. In one patient, sustained 
ventricular tachycardia was induced during the baseline 
period and ventricular fibrillation during nitroprusside infu- 
sion. Thus, the response to programmed cardiac stimulation 
during the two periods differed in only one (8%) of the 
patients. This patient was taking sotalol at the time of study, 
and had hemodynamic changes during nitroprusside infusion 
similar to those of the other patients. 
The mean number of extrastimuli required to induce 
ventricular tachyarrhythmia was similar during the baseline 
period (1.8 k 0.6) and during nitroprusside infusion (1.9 * 
0.7). In seven patients, equal numbers of ventricular extra- 
stimuli induced a tachyarrhythmia during the two pro- 
grammed stimulations. Two patients required one more and 
one patient required one less extrastimulus to induce ven- 
tricular tachycardia during nitroprusside infusion. 
For the nine patients in whom ventricular tachycardia 
was induced during both trials of programmed stimulation, 
the mean tachycardia cycle length was 347 2 61 ms during 
the baseline period and 342 + 70 ms during nitroprusside 
infusion (p = NS) (Fig. 2). The surface ECG configuration of 
the two ventricular tachycardias induced at baseline and 
during nitroprusside infusion was similar in six patients. In 
three patients, morphologically different ventricular tachy- 
cardias were induced during the two programmed stimula- 
tion periods. 
Discussion 
This study evaluates the effects of acute hemodynamic 
improvement on several electrophysiologic variables and on 
the characteristics of ventricular tachycardia induction in 
patients with left ventricular dysfunction and ventricular 
tachycardia due to coronary artery disease. Intravenous ni- 
troprusside administered in doses sufficient to improve hemo- 
dynamic variables and significantly decrease left ventricular 
size failed to change the right ventricular effective refractory 
period and did not affect characteristics of ventricular tachy- 
cardia induction during antiarrhythmic drug therapy. Ventric- 
ular tachycardias induced during nitroprusside infusion were 
similar in cycle length and, in most cases, in surface ECG 
configuration to those induced in the baseline state. 
Previous studies. Studies (10-16) of isolated cardiac tis- 
sue, isolated heart preparations and intact animals have 
suggested an association between cardiac mechanical and 
electrophysiologic properties. Spear and Moore (11) demon- 
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Table 4. Electrophysiologic Measurements in 12 Patients 
VI 
RV ERP at Drive Train 
CL tms) 
Configuratton 
in the Two 
Study IlldUCd Arrhythmia No. of Study 
Patient No. Period SCL (ms) 600 400 Arrhythmia CL tms) Extrastimuli Periods 
I B 810 NSVT 400 
N 700 NSVT 400 
1 B 800 230 VT 320 
N 680 240 VT 320 
3 B 780 250 220 VT 340 
N 760 250 240 VT 32s 
4 B 1000 310 290 NIA 
N 870 300 270 NIA 
s B 970 260 VT 360 
N 700 260 VT 360 
6 B 860 VT 240 
N 680 VT 2 I 0 
7 B 800 250 250 VT 430 
N 730 260 230 VT 420 
8 B 800 260 220 NIA 
N 680 260 220 NIA 
9 B 1350 260 250 VT 
N 1250 270 240 VF 
2x0 
IO B 770 
N 650 
270 
270 
290 
280 
330 
350 
240 VT ‘80 
260 VI 270 
II B 800 
N 800 
270 VT 350 
260 VT 350 
I? B 
N 
Mean t SD B 
N 
P< 
1500 
1250 
937 t 242 
812 + 213 
0.0002 
VT 400 
VT 420 
271 2 30 249 t 25 347 f 61 1.8 k 0.6 
274 2 31 246 + 18 342 + 70 I.9 !I 0.7 
NS NS NS NS 
- 
I 
2 
I 
I 
2 
2 
? 
I 
3 
3 
2 
3 
2 
2 
2 
2 
2 
2 
I 
I 
Same 
Different 
Same 
Same 
Ditferent 
Same 
Same 
Same 
Different 
CL = cycle length: NIA = no inducible arrhythmia; NSVT = nonsustained ventricular tachycardia: RV ERP = 
right ventricular effective refractory period: SCL = sums cycle length: VF = ventricular fibrillation: VT = 
ventricular tachycardia; other abbreviations as in Table I, 
strated that alterations in the action potential of mammalian canine model, demonstrated that late diastolic papillary 
myocardium result from alterations in contractile force. muscle traction during atria1 pacing was associated with 
Other investigators (10,13) have shown that myocardial earlier local ventricular activation. altered QRS configura- 
stretch during diastole can cause rest membrane potential tion and prolongation of the relative refractory period. In a 
depolarization, which, in turn, may generate premature canine model of recent myocardial infarction, Tobler et al. 
action potentials. Changes in action potential amplitude. (23) demonstrated changes in the ventricular effective refrac- 
action potential duration and conduction velocity have tory period near the infarct border zone during transient 
been noted as a result of stretch applied to myocardium aortic occlusion. Calkins et al. (24) noted a reduction in the 
(12,14,15). Recently, Gornick et al. (16), using an open chest absolute refractory period when left ventricular volume was 
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STUDY PATIENTS 
Sustained Nonsustoined VT at Baseline 
VT at Bosellne VT at Baselme 
and on and on 
VFon Nitroprusside 
Nttmprusslde Nitroprusside 
Figure 1. Results of electrophysiologic study at baseline and during 
nitroprusside infusion in the 12 study patients. Of the 12 patients, 10 
had induction of either ventricular tachycardia (VT) or ventricular 
fibrillation (VF) during both study periods. 
increased in the chronically infarcted canine heart. These 
results suggest that acute changes in left ventricular wall 
tension may affect impulse generation and propagation, 
refractoriness and, in turn, arrhythmogenesis. 
Effects of acute hemodynamic improvement in humans. 
Several clinical studies (2,4-7) have demonstrated an asso- 
ciation between the severity of congestive heart failure and 
the frequency and severity of ventricular arrhythmias. If 
increased wall tension is a significant proarrhythmic factor in 
cardiomegaly, decreasing chamber size and wall tension 
would be expected to decrease the incidence of arrhythmias. 
Although this hypothesis has never been tested directly, a 
reduction in *ventricular ectopic activity has been noted 
during long-term treatment of patients with heart failure with 
either captopril(l9) or enalapril(20). Two studies, V-HEFT1 
Figure 2. Ventricular tachycardia cycle length at baseline (B) study 
and during nitroprusside (N) infusion for the nine patients with 
ventricular tachycardia during both study periods. 
foe p = NS 
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(17) and CONSENSUS (18), demonstrated a reduced mor- 
tality rate when hydralazine and isosorbide dinitrate, or 
enalapril, respectively, were added to the therapy of patients 
with heart failure. In the CONSENSUS study (18), however, 
the improved mortality rate was limited to that due to 
hemodynamic deterioration; no change in the incidence of 
sudden death was noted in patients taking enalapril. 
In our study, the influence of the hemodynamic effect of 
nitroprusside on left ventricular size was demonstrated by a 
3% to 7% decrease in ventricular linear dimension and a 7% 
to 19% decrease in cross-sectional area (Table 3). These 
figures correspond approximately to the 13% reduction in 
ventricular volume resulting from nitroprusside infusion 
reported in a previous study (25) of patients with heart 
failure. This hemodynamic improvement did not, however, 
affect the right ventricular effective refractory period or the 
response to programmed cardiac stimulation. These findings 
suggest that, in patients with coronary artery disease and left 
ventricular dysfunction, acute hemodynamic improvement 
does not alter the substrate responsible for the initiation and 
maintenance of sustained ventricular tachycardia. 
Influence of catecholamines. Experimental and clinical 
observations have implicated catecholamines in the patho- 
genesis of ventricular arrhythmias in heart failure. In dogs, 
exogenous catecholamines decrease the ventricular effective 
refractory period, and sympathetic stimulation may cause 
temporal dispersion in recovery of myocardial excitability, 
effects that may predispose to arrhythmias (26). Isoprotere- 
no1 administered during programmed cardiac stimulation 
may facilitate induction of ventricular tachycardia (27,28). 
Morady et al. (29) found that plasma norepinephrine concen- 
trations increased, but that plasma epinephrine concentra- 
tions did not change during induction of ventricular tachy- 
cardia. Increases in plasma norepinephrine, however, were 
not associated with changes in the ventricular effective 
refractory period or characteristics of ventricular tachycar- 
dia induction. In our study, plasma norepinephrine concen- 
tration was higher during nitroprusside infusion than during 
the baseline period, whereas epinephrine concentration was 
unchanged. Nitroprusside infusion caused a significant de- 
crease in sinus cycle length, but not in the ventricular 
refractory period, presumably because of a greater sympa- 
thetic influence on the sinus node than on the myocardium. 
Nevertheless, the possibility that an increase in plasma 
norepinephrine concentration counteracted a potential ben- 
eficial effect of nitroprusside infusion in suppressing ventric- 
ular tachycardia cannot be excluded. 
Limitations of the study. Several limitations of our study 
should be considered. First, this study was conducted in a 
small, homogeneous and selected group of patients; all had 
left ventricular dysfunction due to coronary artery disease 
and all responded to baseline programmed stimulation with 
sustained monomorphic ventricular tachycardia. Therefore, 
our results cannot be generalized to patients with compara- 
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ble left ventricular dysfunction but without coronary artery 
disease. Furthermore, in patients with left ventricular dys- 
function of any cause, the baseline response to programmed 
cardiac stimulation may be nonsustained ventricular tachy- 
cardia or ventricular fibrillation rather than sustained mono- 
morphic ventricular tachycardia; in these patients, unlike 
our study group, the response to programmed stimulation 
might be influenced by changes in hemodynamic variables. 
Thus, our findings can not be generalized to patients in 
whom the response to programmed stimulation is different 
from sustained monomorphic ventricular tachycardia. 
Second, cdl 12 patients n’ere receiving antiarrhythmic 
drug therapy at the time of study. Our inclusion criteria did 
not require persistent presence of induced ventricular tachy- 
cardia with antiarrhythmic drug therapy, as evident from the 
inclusion of the two patients with no induced tachycardia on 
such therapy. However, because inducible ventricular 
tachycardia persisted in the majority (83%) of the patients, 
our study predominantly investigated the effect of hemody- 
namic improvement on persistently inducible ventricular 
tachycardia in patients being treated with antiarrhythmic 
drugs. Our results, therefore, cannot be generalized to 
patients who are not taking such drugs. 
A more technical limitation involves the ventriculur efec- 
tive refractory period, which was measured at the right 
ventricular apex. In previous studies (23,24), the effects of 
hemodynamic changes on ventricular refractoriness were 
greatest in or near infarcted tissue. Our study does not 
exclude possible substantial changes in the myocardial effec- 
tive refractory period at sites other than the right ventricular 
apex, particularly those in the infarct border zone. 
Although all of the patients had depressed left ventricular 
ejection fraction, none had clinically decompensated heart 
failure at the time of study. The baseline filling pressures 
observed in our study may not have been elevated suffi- 
ciently to affect electrophysiologic variables. Therefore, we 
cannot exclude the possibility that patients with decompen- 
sated heart failure would demonstrate changes in electro- 
physiologic variables during nitroprusside infusion. To effect 
a small change in ventricular refractoriness, Calkins et al. 
(24) increased left ventricular volume by >lOO%. In the 
study by Tobler et al. (23), peak left ventricular systolic 
pressure increased by 93 2 28 mm Hg. Changes in hemody- 
namic variables in our study did not approach the magnitude 
of the changes in either of these studies. However, induction 
of ventricular tachycardia did not change, even in the six 
patients whose baseline mean pulmonary capillary wedge 
pressure was >20 mm Hg. These data are consistent with the 
preliminary data of Kulick et al. (30), who studied patients 
with dilated cardiomyopathy in hemodynamically decom- 
pensated and compensated (with nitroprusside) states. They 
demonstrated no differences between the two states in right 
ventricular effective refractory period or inducibility of 
ventricular tachyarrhythmias. However. their patients were 
different from ours in that they had not previously had 
spontaneous sustained ventricular tachycardia. 
Finally, in patients with heart jiiilure, long-term rather 
than short-term hemodynamic improvement may he re- 
quired to alter the electrophysiologic characteristics of the 
diseased myocardium and ventricular tachycardia induction 
characteristics. Experimental observations by Pfeffer et al. 
(31). who showed that long-term treatment with vasodilators 
decreased left ventricular remodeling and improved left 
ventricular performance after myocardial infarction in rats, 
may be applicable to other species as well and may be 
relevant to long-term changes in electrophysiologic charac- 
teristics of the myocardium. Modulation of electrophysio- 
logic variables associated with these changes in cardiac 
volume and geometry may also occur only after long-term 
vasodilator therapy. 
Conclusions. From our data, we conclude that, in pa- 
tients receiving antiarrhythmic drug therapy for ventricular 
tachycardia associated with left ventricular dysfunction and 
coronary artery disease, short-term hemodynamic improve- 
ment does not result in a concomitant beneficial electrophys- 
iologic effect on the induction characteristics of ventricular 
tachycardia. Determination of whether long-term vasodila- 
tor therapy affects ventricular tachycardia induction requires 
further study. 
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